Literature DB >> 10614533

Management of thyroglobulin-positive, body scan-negative thyroid cancer patients: evidence for the utility of I-131 therapy.

J Robbins1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10614533     DOI: 10.1007/BF03343649

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  6 in total

1.  The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer.

Authors:  R S BENUA; N R CICALE; M SONENBERG; R W RAWSON
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1962-01

Review 2.  The changing role of radioiodine in the management of differentiated thyroid cancer.

Authors:  J C Reynolds; J Robbins
Journal:  Semin Nucl Med       Date:  1997-04       Impact factor: 4.446

3.  Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels.

Authors:  F Pacini; F Lippi; N Formica; R Elisei; S Anelli; C Ceccarelli; A Pinchera
Journal:  J Nucl Med       Date:  1987-12       Impact factor: 10.057

4.  Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays.

Authors:  M Schlumberger; O Arcangioli; J D Piekarski; M Tubiana; C Parmentier
Journal:  J Nucl Med       Date:  1988-11       Impact factor: 10.057

Review 5.  Thyroglobulin measurement. Techniques, clinical benefits, and pitfalls.

Authors:  C A Spencer; C C Wang
Journal:  Endocrinol Metab Clin North Am       Date:  1995-12       Impact factor: 4.741

6.  Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.

Authors:  J D Pineda; T Lee; K Ain; J C Reynolds; J Robbins
Journal:  J Clin Endocrinol Metab       Date:  1995-05       Impact factor: 5.958

  6 in total
  2 in total

1.  Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.

Authors:  N Lima; H Cavaliere; E Tomimori; M Knobel; G Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

Review 2.  Current strategies for surgical management and adjuvant treatment of childhood papillary thyroid carcinoma.

Authors:  Geoffrey B Thompson; Ian D Hay
Journal:  World J Surg       Date:  2004-11-04       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.